GAO: New payment rates for Part B lab tests may lead to billions in overpayments
Medicare’s new method of calculating payment rates for laboratory tests, intended to reduce Medicare spending by $360 million in the first year, could cost the agency billions in overpayments, according to a recent report from the U.S. Government Accountability Office.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.